Cipla reported INR65.92B in Trade Debtors for its fiscal quarter ending in September of 2026.





Trade Debtors Change Date
aTyr Pharma USD 883K 23K Jun/2026
Brainstorm Cell Therapeutics USD 122K 36K Mar/2026
Capricor Therapeutics USD 59K 0 Dec/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cipla INR 65.92B 3.73B Sep/2026
Dr.Reddys Laboratories INR 105.6B 18.81B Sep/2026
Immunic USD 333K 156K Dec/2025
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Sun Pharmaceuticals INR 186.47B 24.38B Sep/2026
TherapeuticsMD USD 2.91M 310K Jun/2024
UPL INR 195.41B 830M Sep/2026